Rainbow BioSciences, LLC and n3D Aim to Help Bring Stem Cell Treatments to Market Faster

March 19, 2012 |

1 min read

Twitter
LinkedIn
Facebook
Email
Print

NOKOMIS, Fla.--(BUSINESS WIRE)--As global demand for innovative new stem-cell therapies grows by the day, Rainbow BioSciences’ (OTCBB:RBCC) new agreement with n3D Biosciences could help to bring these therapies to market faster than ever before.

Twitter
LinkedIn
Facebook
Email
Print

Alliances